| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 12/27/2002 | CA2782761A1 Polymorphic forms of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride |
| 12/27/2002 | CA2782628A1 Polymorphic forms of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride |
| 12/27/2002 | CA2782623A1 Polymorphic forms of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride |
| 12/27/2002 | CA2782615A1 Polymorphic forms of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride |
| 12/27/2002 | CA2782521A1 Polymorphic forms of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoylbenzofuran-5-yl) piperazine hydrochloride |
| 12/27/2002 | CA2782519A1 Polymorphic forms of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoylbenzofuran-5-yl) piperazine hydrochloride |
| 12/27/2002 | CA2782517A1 Polymorphic forms of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoylbenzofuran-5-yl) piperazine hydrochloride |
| 12/27/2002 | CA2782515A1 Polymorphic forms of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride |
| 12/27/2002 | CA2782494A1 Polymorphic forms of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride |
| 12/27/2002 | CA2450936A1 Purine inhibitors of phosphodiesterase (pde) 7 |
| 12/27/2002 | CA2450934A1 Pyrimidine inhibitors of phosphodiesterase (pde) 7 |
| 12/27/2002 | CA2450724A1 Quinazoline and pyrido¬2,3-d|pyrimidine inhibitors of phosphodiesterase (pde) 7 |
| 12/27/2002 | CA2450245A1 4-piperazinylindole derivatives with 5-ht6 receptor affinity |
| 12/27/2002 | CA2450074A1 Acylic piperazine and piperidine derivatives which are useful for treating neuronal damage |
| 12/27/2002 | CA2450067A1 Proteins associated with cell growth, differentiation, and death |
| 12/27/2002 | CA2449977A1 Human growth hormone antagonists |
| 12/27/2002 | CA2449898A1 Krill and/or marine extracts for prevention and/or treatment of cardiovascular diseases, arthritis, skin cancer, diabetes, premenstrual syndrome and transdermal transport |
| 12/27/2002 | CA2449212A1 Alkylidene pyrazolidinedione derivatives and use for treating diabetes and obesity |
| 12/27/2002 | CA2448993A1 Process for the preparation of dispersions |
| 12/27/2002 | CA2446284A1 Method for identification of agents for the treatment of diabetes |
| 12/27/2002 | CA2430627A1 Isolated homozygous stem cells differentiated cells derived therefrom and materials and methods for making and using same |
| 12/26/2002 | US20020198382 For therapy and prophylaxis disorders caused by disturbances of glucose and/or lipid metabolism, such as, for example diabetes type 2, and other insulin-resistant conditions |
| 12/26/2002 | US20020198367 DNA encoding mammalian neuropeptide FF (NPFF) receptors and uses thereof |
| 12/26/2002 | US20020198259 Treatment of disease caused by procedural vascular trauma and/or an increased level of plasma homocysteine |
| 12/26/2002 | US20020198242 Administering to an animal an effective dose of atleast an enzyme Dipeptidyl Peptidase (DP IV) enzyme activity effector to increase the capacity of insulin producing cells |
| 12/26/2002 | US20020198234 Identifying a patient suffering from fatigue arising from oncological condition, and administering to the patient a therapeutically effective amount of D-threo-methylphenidate free of 1-threo isomer |
| 12/26/2002 | US20020198203 Administering (2R)-2-(4-(9-Bromo-2,3-dimethyl-naptho(2,3-b) thiophen-4-yl)-2,6-dimethyl-phenoxy)-3-phenyl-propionic acid to treat metabolic disorders mediated by insulin resistance or hyperglycemia |
| 12/26/2002 | US20020198202 Combination of a PTPase inhibitor and an antilipemic agent |
| 12/26/2002 | US20020198201 Administering (R)-2-(2,6-dibromo-4-(9-bromo-2,3-dimethyl-naphtho(2,3-b)thiophen-4-yl) -phenoxy)-3-phenyl-propionic acid to lower free fatty acid blood levels in diabetic mammals |
| 12/26/2002 | US20020198200 Alpha-acyl- and alpha-heteroatom-substituted benzene acetamide glucokinase activators |
| 12/26/2002 | US20020198194 Neuropeptide Y (NPY) antagonists for the treatment or prevention of arthritis, cardiovascular diseases, diabetes, renal failure, eating disorders, or obesity |
| 12/26/2002 | US20020198179 An estrogen or prodrug micture for reducing or eliminating the incidence of hot flashes and menopausal symptoms, while decreasing the risk of acquiring breast or endometrial cancer, inhibiting the development of osteoporosis |
| 12/26/2002 | US20020198177 Coenzyme Q and EPA |
| 12/26/2002 | US20020198158 A cyclic ether conatining atleast 3 carbon atoms; sugars; useful as antidiabetic agents |
| 12/26/2002 | US20020198152 Administering to an obese patient or one at risk of becoming obese a therapeutic compound that attenuates the binding of agouti-related protein to melanocortin receptors, free of binding of alpha-melanocyte stimulating hormone to receptor |
| 12/26/2002 | US20020198143 B7-like polynucleotides, polypeptides, and antibodies |
| 12/26/2002 | US20020197692 Methods of isolating amyloid-inhibiting compounds and use of compounds isolated from Uncaria tomentosa and related plants |
| 12/26/2002 | US20020197596 Phosphoprotein target for insulin and its antagonists |
| 12/26/2002 | US20020197334 Pharmaceutical composition for the treatment of diabetes mellitus |
| 12/26/2002 | US20020197331 Chromium/biotin treatment of dyslipidemia and diet-induced post prandial hyperglycemia |
| 12/26/2002 | US20020197308 Rapidly soluble drug composition |
| 12/26/2002 | US20020197267 Integrin binding motif containing peptides and methods of treating skeletal diseases |
| 12/25/2002 | CN1387576A Sequence-specific DNA recombination in ekaryotic cells |
| 12/25/2002 | CN1387568A Modified ciliary neurotrophic factor, method of making and methods of use thereof |
| 12/25/2002 | CN1387531A Pyrazolo [4,3-d] pyrimidine derivs. |
| 12/25/2002 | CN1387530A Imidazopyridine derivs. used as phosphodiesterase VII inhibitors |
| 12/25/2002 | CN1387528A Heterocyclic substd, pyrazolones |
| 12/25/2002 | CN1387526A Cyclopropanes as CGRP antagonists, medicaments contg. said compounds and method for production thereof |
| 12/25/2002 | CN1387509A Substd. N-phenyl-2-hydroxy-2-methyl-3,3,3-trifluoropropanamide derivs. which elevate pyruvate dehydrogenase activity |
| 12/25/2002 | CN1387440A Methods for treating diabetes |
| 12/25/2002 | CN1387439A Treatment of diabetic nephropathy and microalbuminuria |
| 12/25/2002 | CN1387430A Liver selective therapy |
| 12/25/2002 | CN1386744A Process for extracting triterpenic acid from gleditschia, and medical use and Chinese medicine of triterpenic acid |
| 12/25/2002 | CN1386742A Flavone derivatives and preparing process and use thereof |
| 12/25/2002 | CN1386546A Capsule 'Yibao Yishou' for elongating life |
| 12/25/2002 | CN1386544A Medicinally health-care powder made of ganoderma and lentinan |
| 12/25/2002 | CN1386539A Formulation for treating diabetes |
| 12/25/2002 | CN1386538A Weight-lossing antihypertensive liquid and its preparing process |
| 12/25/2002 | CN1386537A Oral liquid of hare's-lettuce |
| 12/25/2002 | CN1386527A Chinese medicine composition for treating diabetes and its preparing process |
| 12/25/2002 | CN1386518A Soft capsule made of walnut oil for taking care of brain health |
| 12/25/2002 | CN1386501A Omega-3 fatty acid capsule |
| 12/25/2002 | CN1386500A Application of diphenylvinyl phenol glucoside compounds in preparing hypoglycemic medicine |
| 12/25/2002 | CN1386499A Application of diphenylvinyl phenol glucosides in preparing hypolipemic medicine |
| 12/25/2002 | CN1386440A Health-care food for regulating blood sugar and blood fat |
| 12/25/2002 | CN1097053C 1,2,3,4-tetrahydro-benzofuro [3,2-c] pyridine derivs., preparing method and use thereof |
| 12/25/2002 | CN1097051C N-heteroaryl-pyridinesulfonamide derivs. and their use as endotheliin antagonists |
| 12/25/2002 | CN1096865C Chinese patent medicine for traeting diabets |
| 12/24/2002 | US6498275 Use of compounds for the elevation of pyruvate dehydrogenase activity |
| 12/24/2002 | US6498274 Amide derivatives for the treatment of diseases mediated by cytokines |
| 12/24/2002 | US6498191 For treatment of alzheimer's disease, diabetes mellitus, parkinson's disease, neuronal and cardiac ischemia, huntington's disease, stroke |
| 12/24/2002 | US6498182 Compounds |
| 12/24/2002 | US6498174 Agonists to peroxisome proliferator-activated receptors; modulating blood glucose and lipid levels; reducing dyslipidemia and hyperinsulinemia associated with impaired glucose tolerance or metabolic syndrome |
| 12/24/2002 | US6498170 4-((2s)-3-(1-(4-butoxy-benzenesulfonyl)-azetidin-3-ylamino)-2 -hydroxy- propoxy)-phenol for example; hypoglycemic agent; increasing lean meat to fat ratio in mammals |
| 12/24/2002 | US6498156 Diphenylazetidinone derivatives, process for their preparation, medicaments comprising these compounds and their use |
| 12/24/2002 | US6498151 Aryldifluoromethylphosphonic acids with sulfur-containing substituents as PTP-1B inhibitors |
| 12/24/2002 | US6498142 Osteogenic protein-1 (op-1) and other members of the op-1 subfamily of the tgf-.beta. superfamily of growth factors |
| 12/24/2002 | US6497906 Anticholesterol, reduced menstrual bleeding |
| 12/24/2002 | CA2075878C Cyclic peptides and use thereof |
| 12/24/2002 | CA2054339C 3-amidoindolyl derivatives |
| 12/24/2002 | CA2038984C Hydroxymethyl-indolizidines and quinolizidines |
| 12/23/2002 | WO2001098255A1 Process for the production of calcium pantothenate |
| 12/23/2002 | CA2413413A1 Method for preparing calcium pantothenate |
| 12/21/2002 | CA2390966A1 Compound for the treatment of atherosclerotic-thrombotic pathological conditions |
| 12/21/2002 | CA2390757A1 Method of decreasing fasting sugars and weight gains in diabetic patients |
| 12/19/2002 | WO2002101392A2 Methods for treating disorders of the nervous and reproductive systems |
| 12/19/2002 | WO2002101074A2 Nucleic acid constructs useful for glucose regulated production of human insulin in somatic cell lines |
| 12/19/2002 | WO2002101069A2 Ns4 nucleic acids and polypeptides and methods of use for the treatment of body weight disorders |
| 12/19/2002 | WO2002101048A2 NEW POLYNUCLEOTIDES AND POLYPEPTIDES OF THE IFNα-7 GENE |
| 12/19/2002 | WO2002101005A2 A g-protein coupled receptor and uses therefor |
| 12/19/2002 | WO2002100888A1 Somatostatin-dopamine chimeric analogs |
| 12/19/2002 | WO2002100862A2 Novel substituted tetracyclic imidazole derivatives, processes for their preparation, pharmaceutical compositions comprising them and their use as a medicine |
| 12/19/2002 | WO2002100859A1 Pde iv inhibitors |
| 12/19/2002 | WO2002100857A1 Quinuclidines-substituted-multi-cyclic-heteroaryls for the treatment of disease |
| 12/19/2002 | WO2002100849A2 Novel nitriles useful as reversible inhibitors of cysteine proteases |
| 12/19/2002 | WO2002100822A1 Substituted sulfonamide compounds, process for their use as medicament for the treatment of cns disorders, obesity and type ii diabetes |
| 12/19/2002 | WO2002100813A2 Modulators of peroxisome proliferator activated receptors |
| 12/19/2002 | WO2002100812A1 Carboxylic acid derivative and salt thereof |
| 12/19/2002 | WO2002100456A1 Using supercritical fluids to infuse therapeutic on a medical device |
| 12/19/2002 | WO2002100422A1 Pharmaceutical formulation consisting of a plant dry extract with a calcium coating |